• With patient compliance as a top concern, there is increasing interest in taste masking as the pharmaceutical industry invests more resources into the development of palatable and pleasant tasting...

    Publication
     
  • With greater use of SDDs as an integral part of the formulation toolbox, and a considerable portfolio of SDDs progressing toward commercialization, adoption of a Quality-by-Design (QbD)-based...

    Publication
     
  • To gauge emerging trends in solid dosage manufacturing, Pharmaceutical Technology spoke with Randy Wald, senior research fellow at Bend Research, part of Capsugel Dosage Form Solutions about key...

    Publication
     
  • This article presents a streamlined, de-risked approach, based on spray dry technology, which has been optimized for inhaled drug development.

    Publication
     
  • Enteric capsule drug delivery technology (ECDDT) was developed to provide oral delivery with full enteric protection and rapid release in the GI tract without the use of coatings. ECDDT’s...

    Webinar
     
  • Bend Research's Dan Dobry contributed to the article, “Solving Poor Solubility to Unlock a Drug’s Potential" in the July 2015 Pharmaceutical Technology Europe publication

    Publication
     
  • Capsugel Dosage Form Solution's Dr. David Vodak was quoted in Drug Development and Delivery’s July issue focused on The Global Formulation Report.

    Publication
     
  • Capsugel / Bend Research experts describe efforts to develop integrated biotherapeutic manufacturing hardware and software technologies to reduce risk and optimize our clients' fed-batch and...

    Webinar
     
  • A common problem statement in the pharmaceutical industry is low oral bioavailability of drug candidates with poor aqueous solubility. The literature suggests that a significant majority of new drug...

    White Paper
     
  • Enteric capsule drug delivery technology (ECDDT) was developed to provide oral delivery with full enteric protection and rapid release in the upper gastrointestinal (GI) tract without the use of...

    Publication
     
  • Peptide YY3-36 [PYY(3-36)] has shown efficacy in appetite suppression when dosed by injection modalities (intraperitoneal (IP)/subcutaneous). Transitioning to needle-free delivery, towards inhalation...

    Publication
     
  • Drug Discovery & Development published an article titled, “Nanotechnology Applications in Drug Delivery,” authored by Bend Research/Capsugel DFS’ Mike Morgen.

    Publication
     

Pages